Original language | English |
---|---|
Pages (from-to) | 2447-2449.e2 |
Journal | Journal of Allergy and Clinical Immunology: In Practice |
Volume | 7 |
Issue number | 7 |
DOIs | |
State | Published - Sep 1 2019 |
Externally published | Yes |
Fingerprint
Dive into the research topics of 'Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma. / Bachert, Claus; Hellings, Peter W.; Mullol, Joaquim; Naclerio, Robert M.; Chao, Jingdong; Amin, Nikhil; Grabher, Annette; Swanson, Brian N.; Hamilton, Jennifer D.; Guillonneau, Sophie; Taniou, Christine; Zhang, Donghui; Pirozzi, Gianluca; Graham, Neil M.H.; Staudinger, Heribert; Mannent, Leda P.; Khan, Asif.
In: Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, No. 7, 01.09.2019, p. 2447-2449.e2.Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma
AU - Bachert, Claus
AU - Hellings, Peter W.
AU - Mullol, Joaquim
AU - Naclerio, Robert M.
AU - Chao, Jingdong
AU - Amin, Nikhil
AU - Grabher, Annette
AU - Swanson, Brian N.
AU - Hamilton, Jennifer D.
AU - Guillonneau, Sophie
AU - Taniou, Christine
AU - Zhang, Donghui
AU - Pirozzi, Gianluca
AU - Graham, Neil M.H.
AU - Staudinger, Heribert
AU - Mannent, Leda P.
AU - Khan, Asif
N1 - Funding Information: Editorial assistance was provided by Bilge Yoruk, PhD, and Ravi Subramanian, PhD, of Excerpta Medica funded by Sanofi Genzyme and Regeneron Pharmaceuticals . Funding Information: The research was sponsored by Sanofi and Regeneron Pharmaceuticals.Conflicts of interest: C. Bachert is the principal investigator of the study, and serves on the advisory boards of ActoBiotics, ALK, ASIT Biotech, AstraZeneca, Novartis, Sanofi, and Stallergenes. P. W. Hellings serves on the advisory board of Regeneron Pharmaceuticals, Inc. J. Mullol is the member of national and international scientific advisory boards (consulting) of and receives fees for lectures and grants for research projects from ALK-Abell?, Allakos, FAES, Genentech, Glenmark, GSK, Mylan, Menarini, MSD, Novartis, Regeneron Pharmaceuticals, Sanofi Genzyme, UCB, and Uriach. R. M. Naclerio serves on the advisory board of ActoBiotics, Genentech, Novartis, and Sanofi; and is on the speaker's bureau of Optinose. J. Chao, N. Amin, J. D. Hamilton, and N. M. H. Graham are employees and shareholders of Regeneron Pharmaceuticals, Inc. A. Grabher, S. Guillonneau, D. Zhang, G. Pirozzi, H. Staudinger, L. P. Mannent, and A. Khan are employees of Sanofi and may hold stock and/or stock options in the company. B. N. Swanson is the former Sanofi employee and may hold stock or stock options in the company. C. Taniou is the employee of Altran Technologies.Editorial assistance was provided by Bilge Yoruk, PhD, and Ravi Subramanian, PhD, of Excerpta Medica funded by Sanofi Genzyme and Regeneron Pharmaceuticals. Funding Information: The research was sponsored by Sanofi and Regeneron Pharmaceuticals.Conflicts of interest: C. Bachert is the principal investigator of the study, and serves on the advisory boards of ActoBiotics, ALK, ASIT Biotech, AstraZeneca, Novartis, Sanofi, and Stallergenes. P. W. Hellings serves on the advisory board of Regeneron Pharmaceuticals, Inc. J. Mullol is the member of national and international scientific advisory boards (consulting) of and receives fees for lectures and grants for research projects from ALK-Abelló, Allakos, FAES, Genentech, Glenmark, GSK, Mylan, Menarini, MSD, Novartis, Regeneron Pharmaceuticals, Sanofi Genzyme, UCB, and Uriach. R. M. Naclerio serves on the advisory board of ActoBiotics, Genentech, Novartis, and Sanofi; and is on the speaker's bureau of Optinose. J. Chao, N. Amin, J. D. Hamilton, and N. M. H. Graham are employees and shareholders of Regeneron Pharmaceuticals, Inc. A. Grabher, S. Guillonneau, D. Zhang, G. Pirozzi, H. Staudinger, L. P. Mannent, and A. Khan are employees of Sanofi and may hold stock and/or stock options in the company. B. N. Swanson is the former Sanofi employee and may hold stock or stock options in the company. C. Taniou is the employee of Altran Technologies.Editorial assistance was provided by Bilge Yoruk, PhD, and Ravi Subramanian, PhD, of Excerpta Medica funded by Sanofi Genzyme and Regeneron Pharmaceuticals. Funding Information: The research was sponsored by Sanofi and Regeneron Pharmaceuticals .
PY - 2019/9/1
Y1 - 2019/9/1
UR - http://www.scopus.com/inward/record.url?scp=85064194313&partnerID=8YFLogxK
U2 - 10.1016/j.jaip.2019.03.023
DO - 10.1016/j.jaip.2019.03.023
M3 - Article
C2 - 30928658
AN - SCOPUS:85064194313
VL - 7
SP - 2447-2449.e2
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
SN - 2213-2198
IS - 7
ER -